Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface:...

Area of Science:

• Biomaterials Science
• Immunology
• Nanotechnology

Background:

• Polyethyleneoxide (PEO) chains on nanoparticles offer stealth properties for drug delivery and imaging.
• The human complement cascade, part of innate immunity, can cause adverse reactions when activated by nanoparticles.
• Understanding the structure-activity relationship of PEO configurations is crucial for safe nanomedicine.

Purpose of the Study:

• To investigate how different configurations of surface-immobilized PEO chains on nanoparticles affect complement cascade initiation.
• To elucidate the structure-activity relationship between PEO conformation and complement activation pathways.
• To provide a basis for designing safer, immunologically inert nanosystems.

Main Methods:

• Adsorption of poloxamine 908 block copolymer onto polystyrene nanoparticles.
• Analysis of PEO chain configurations (mushroom, brush, transition).
• Assessment of complement activation pathways (classical, lectin, alternative) and complement activation products (C4d, Bb, C5a, SC5b-9).

Main Results:

• PEO chain configuration significantly alters complement activation.
• Switching from mushroom to brush configuration shifts activation from the classical to the lectin pathway.
• Reduced levels of complement activation products were observed with brush configurations.
• Properdin-mediated alternative pathway activation was specific to the mushroom-brush transition configuration.

Conclusions:

• Nanoparticle surface engineering, specifically PEO configuration, is critical for modulating immune response.
• Designing nanoparticles with specific PEO architectures can minimize complement activation.
• Findings support the development of safer stealth and targetable nanosystems for clinical use.